Trending Articles

article thumbnail

A closer look at how health care consolidation drives up patient costs, creates barriers to care

PhRMA

Half of every dollar spent on medicines goes to entities that don’t make medicine—like pharmacy benefit managers (PBMs) and insurers who are aggressively consolidating their control over health care and hospitals, clinics and for-profit pharmacies in the 340B markup program. As entities in the supply chain that don’t make medicine are increasingly using medicines to subsidize other parts of their business, patients and employers face increasing costs and barriers to accessing c

Insurance 268
article thumbnail

Pharmacy Buprenorphine Programs Can Increase OUD Treatment Access, But Barriers Limit Engagement

Drug Topics

The top reported barriers to providing buprenorphine included regulatory and administrative, operational and attitudinal, and patient-related challenges.

468
468
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bipartisan Bill Aims to Combat PBMs’ Medicaid Spread-Pricing

Drug Topics

US Senators on both sides of the aisle came together to announce the Protecting Pharmacies in Medicaid Act.

584
584
article thumbnail

Private equity ‘gobbling’ up care facilities for people with disabilities

STAT

Private equity firms are acquiring facilities that care for people with intellectual or developmental disabilities at an alarming rate, according to a new report released Tuesday. The care industry for this population has been historically owned and operated by nonprofits and faith-based institutions. However, between 2013 and 2023, private equity firms made over 1,000 acquisitions of disability and elder care providers — a likely undercount, according to the report published by the Priva

141
141
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

7 health benefits of raspberry leaf tea

The Checkup by Singlecare

Raspberries are vibrant, juicy, and somewhat tart berries known for their rich fiber and antioxidant content. The berries are plucked and enjoyed as a healthy snack or topping on oatmeal and yogurt. But did you know that the leaves of the raspberry plant ( Rubus idaeus ) may have health benefits, too? You may have heard of red raspberry leaf tea. It is a caffeine-free herbal tea made from the dried leaves of the fruit-bearing plant.

article thumbnail

Lawmakers tease out pharma’s influence over RFK Jr. through probe into Mar-a-Lago meetings

PharmaVoice

HHS head Robert F. Kennedy Jr. has long been an opponent of pharma influence in government. U.S. lawmakers are asking whether unofficial Mar-a-Lago meetings point to a change of heart.

217
217

More Trending

article thumbnail

Drug Shortages, Affordability Remain Top Concerns in Managed Care Pharmacy

Drug Topics

Approximately, 62% of respondents stated that the number of active drug shortages could potentially increase by more than 25% within the next 5 years.

516
516
article thumbnail

STAT+: Congress created a unique plan to save rural hospitals — but few are using it

STAT

When Ted Matthews came out of retirement in early 2023 to retake the helm of the rural Texas hospital where he’d started his health care career, it was something of a rescue mission. They were having bake sales to keep the place afloat. Staff were updating their resumes. At every board meeting, they’d decide which bills to pay.  “It was the consensus that we were going to be that twenty-seventh rural hospital in Texas to close,” said Matthews, interim CEO of Anso

Hospitals 130
article thumbnail

Does pravastatin cause weight gain?

The Checkup by Singlecare

If youre one of the 47 million Americans who take a medication to treat high cholesterol, you may have heard of pravastatin , a statin drug that is approved by the Food and Drug Administration (FDA) to lower bad cholesterol levels and help prevent heart disease. While pravastatin, also sold under the brand name Pravachol, does not directly cause weight gain, some people may notice slight changes in their weight after starting the medication.

FDA 71
article thumbnail

Counseling Patients About Pharmacologic Therapy for Menopausal Symptoms

Pharmacy Times

Panelists discuss how health care professionals develop personalized menopause management strategies by comprehensively assessing individual medical history, symptom profiles, lifestyle factors, and potential risks. Through transparent, collaborative counseling, they guide patients in making informed decisions about pharmacologic therapies, prioritizing personalized care and holistic well-being.

65
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Which Social Media Analytics Matter Most in Pharma Marketing

Pharma Marketing Network

Introduction Social media has become an essential tool for pharmaceutical marketing. However, simply posting content is not enough. To measure success and improve engagement, pharma marketing teams must focus on the right social media analytics. But which metrics truly matter? With increasing regulations, evolving digital trends, and shifting audience behaviors, pharma marketers need to analyze data that aligns with brand goals, compliance requirements, and engagement strategies.

HIPAA 52
article thumbnail

STAT+: Teenager who received Elevidys, Sarepta’s Duchenne gene therapy, dies 

STAT

Sarepta Therapeutics said Tuesday that a 16-year-old boy died after receiving Elevidys, its gene therapy for Duchenne muscular dystrophy, the first known death linked to the treatment. The teenager suffered liver failure, a side effect that has been seen with other gene therapy treatments over the last two decades.  Sarepta said in its statement that a recent cytomegalovirus infection could have also contributed to the patient’s death, putting him at heightened risk.

134
134
article thumbnail

The Issue with Reissue: PTE Edition

The FDA Law Blog

By Sara W. Koblitz Integral to the careful balance Congress struck when passing the Hatch-Waxman Amendments, the patent term extension (PTE) is intended to restore patent life that was consumed during regulatory review of an FDA-regulated product. Even though the PTE provisions established in the Drug Price Competition and Patent Restoration Act are forty-plus years old, courts are still grappling with questions about how to best implement the Patent Term Extension.

article thumbnail

How non-traditional investors fuel up-and-coming biotechs when VC funding dries up

PharmaVoice

Smaller biotechs are finding creative ways to fund R&D at a time when the traditional financing channels have become more constrictive.

147
147
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Audience Engagement Strategies for Pharma Marketing: Boost HCP and Patient Interaction

Pharma Marketing Network

Introduction In the highly regulated pharmaceutical industry, audience engagement is more than just a marketing goalit is a necessity for building trust with healthcare professionals (HCPs) and patients. But how can pharma brands create meaningful connections in a digital landscape crowded with content? Unlike traditional consumer marketing, pharma marketing requires a strategic approach that balances compliance, education, and innovation.

article thumbnail

Gilead Presents Data Demonstrating Established, Investigational HIV Drugs

Drug Topics

Among the drugs presented, Biktarvy and lenacapavir, teropavimab, and zinlirvimab (LTZ) demonstrate rates of suppression of HIV, and vesatolimod is well tolerated.

415
415
article thumbnail

STAT+: CRISPR company Arbor Biotechnologies gets cash infusion from ARCH

STAT

Three years ago, Arbor Biotechnologies CEO Devyn Smith appeared at the J.P. Morgan Healthcare Conference and laid out a grand vision: With $215 million in new capital, the biotech would push forward CRISPR-based drugs for a series of liver and brain diseases, beginning by filing for a first trial in under two years.  It was, suffice to say, bold.

123
123
article thumbnail

Novo Nordisk industry membership reinstated

European Pharmaceutical Review

Novo Nordisk has regained full membership with the Association of the British Pharmaceutical Industry (ABPI), following suspension in 2023. This action resulted after the pharmaceutical company made serious breaches of the ABPI Code of Practice in 2021. The case was the eighth instance in the past four decades that the ABPIs board has issued this degree of sanction, the industry body highlighted upon announcing the news.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Drug developers ‘haven’t even scratched the surface’ of what radiopharma can do

PharmaVoice

Even with Big Pharmas pouring billions into the space, the potential of radiopharmaceuticals remains largely untapped.

147
147
article thumbnail

The future of clinical pharmacy in Europe with ESCP president Monika Lutters

Hospital Pharmacy Europe

In an era of rapid healthcare evolution, clinical pharmacy is at a crossroads in Europe, facing both unprecedented opportunities and pressing challenges, and Dr Monika Lutters, ESCP president, is at the forefront of these developments. Here, speaking to Gerry Hughes, she shares her insights on current clinical pharmacy challenges around expansion and integration of hospital pharmacists, and the exciting trajectory this branch of pharmacy is set to undertake in the years ahead.

article thumbnail

Automated Insulin Delivery Could Be Used for Older Adults With Type 1 Diabetes

Drug Topics

These findings challenge the common assumption that older adults might struggle to use more advance medical devices.

415
415
article thumbnail

Opinion: Banning direct-to-consumer drug ads won’t work

STAT

As a reformed hypochondriac, I’m extremely vulnerable to the allure of pharmaceutical ads. I self-referred for GLP-1s years ago after seeing advertisements, and even though I am a diabetic, what followed were horrific health outcomes: hospitalizations, extensive procedures, scans, MRIs, pancreatitis, anemia, and thousands in medical expenses.

article thumbnail

Tirzepatide vs. semaglutide: Differences & similarities explained

The Checkup by Singlecare

Tirzepatide and semaglutide have exploded in popularity over the past few years, primarily due to their weight loss benefits. Tirzepatide is the active ingredient in both Mounjaro and Zepbound , while semaglutide is the active ingredient in Ozempic , Wegovy , and Rybelsus (an oral medicine). These medications act like natural hormones in the body, regulating appetite and reducing food noise (intrusive thoughts about food that interfere with weight loss efforts).

article thumbnail

Takeda’s $770M deal deepens Big Pharma’s omics push

PharmaVoice

The pharma giant announced a new partnership with BridGene Biosciences that will use its IMTAC platform for drug discovery.

147
147
article thumbnail

First cardiology consultant pharmacist appointed in Scotland to improve patient outcomes

Hospital Pharmacy Europe

Scotlands first cardiology consultant pharmacist has been appointed by NHS Golden Jubilee to provide professional leadership and mentorship and improve patient outcomes across the region. Paul Forsyth, who has 20 years experience working with cardiac patients, most recently as a heart failure pharmacist and lead pharmacist in clinical cardiology (primary care) at NHS Greater Glasgow and Clyde, will work across organisational boundaries to support cardiology lead pharmacists in the west of Scotla

article thumbnail

Zero Cases of HIV Acquisition Seen for Apretude, Cabenuva Treatment

Drug Topics

Additional data shows that an investigational drug, given every 4 months with Apretude, kept viral levels suppressed for patients who were already on stable treatment.

394
394
article thumbnail

STAT+: Belgian anti-trust authorities probe Roche for allegedly delaying biosimilars of two cancer meds

STAT

Belgian anti-trust regulators are probing Roche over concerns that the drug company took steps to delay the entry of biosimilar versions of two of its cancer medicines. In a brief statement , the Belgian Competition Authority alleged that Roche offered financial incentives to hospitals between 2017 and 2020 to deter them from considering competitive bids from other pharmaceutical companies that could supply similar medicines.

article thumbnail

Diclofenac vs. naproxen: Differences & similarities explained

The Checkup by Singlecare

For many people with pain or inflammation, healthcare providers often prescribe medications like diclofenac or naproxen. These drugs belong to a group called nonsteroidal anti-inflammatory drugs (NSAIDs). Diclofenac and naproxen may help reduce inflammation and relieve pain caused by conditions like arthritis, menstrual cramps, or migraines. While both medications can help people relieve pain and discomfort that interferes with daily activities, they may differ in various ways.

Dosage 52
article thumbnail

Teen’s death following Sarepta DMD gene therapy underscores a risk seen for decades

PharmaVoice

The death of a 16-year-old boy evokes a lengthy battle to realize the benefit of cutting-edge gene therapy while also enduring tragic risk.

130
130
article thumbnail

Strategies For A Pharma Ad Ban on TV

Pharma Marketing Network

Table of Contents The Impact of a Pharma Ad Ban on TV Digital Marketing as a Primary Alternative Leveraging Data-Driven Advertising Strategies Strengthening Direct-to-Consumer (DTC) Engagement The Impact of a Pharma Ad Ban on TV The potential for a pharma ad ban on TV has sparked intense discussions among marketing executives. If regulations change, pharmaceutical brands must rethink their advertising strategies to maintain visibility and patient engagement.

59
article thumbnail

Over 300 Pharmacy Closures Reported in the Last 3 Months

Drug Topics

A new report from the American Economic Liberties Project presents the continued challenges pharmacies face since Congress failure to pass PBM reform at the end of 2024.

346
346
article thumbnail

STAT+: After a big donor sought care from a Dana-Farber cancer doctor, things went awry

STAT

Day or night, Marc Cohen, a major donor to Dana-Farber Cancer Institute, had a direct line to one of its leading oncologists. No question was too big or too small, and almost no hour was off limits for a consultation. Cohen and his doctor, Kenneth C. Anderson, exchanged hundreds of emails and texts over two decades about Cohen’s disease, multiple myeloma, a rare and incurable blood cancer that is Anderson’s specialty.

article thumbnail

Cyclobenzaprine vs. baclofen: Differences & similarities explained

The Checkup by Singlecare

Muscle spasms and stiffness can be painful and uncomfortable, with healthcare providers often prescribing medications like cyclobenzaprine or baclofen to help. These drugs are muscle relaxants used to relieve spasms from musculoskeletal conditions, nerve problems, or spinal cord injuries. They help relax muscles and reduce pain, providing people with much-needed relief.